Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H2 O2-Reference-Cited by-同舟云学术

Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H2 O2

Published:2013-05-30 Issue:2 Volume:126 Page:234-242
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Feng Ye¹,Xia Yiyuan¹,Yu Guang¹,Shu Xiji²,Ge Haoliang¹,Zeng Kuan¹,Wang Jianzhi¹,Wang Xiaochuan¹

Affiliation:

1. Department of Pathophysiology; Key Laboratory of Neurological Disease of National Education Ministry; Tongji Medical College; Huazhong University of Science and Technology; Wuhan China

2. Department of Pathology & Pathophysiology; School of Medicine; Jianghan University; Wuhan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.12285/fullpdf

Reference42 articles.

1. Mechanism of activation of protein kinase B by insulin and IGF-1;Alessi;EMBO J.,1996

2. Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways;Blair;J. Biol. Chem.,1999

3. Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β;Cedazo-Minguez;J. Neurochem.,2003

4. Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130;Cicchillitti;J. Biol. Chem.,2003

5. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition;Dajani;Cell,2001

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin: A potential nighttime guardian against Alzheimer’s;Molecular Psychiatry;2024-08-11

2. Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress‐induced neuronal loss and related neurological deficits;CNS Neuroscience & Therapeutics;2024-07

3. Tau‐targeting nanoparticles for treatment of Alzheimer's disease;Exploration;2024-06-21

4. Experimental verification about treatment of Bu-Shen-Yi-Jing-Fang in Alzheimer’s disease by the analysis of the feasible signaling pathway of network pharmacology;BMC Complementary Medicine and Therapies;2024-06-08

5. Hypotension with neurovascular changes and cognitive dysfunction: An epidemiological, pathobiological, and treatment review;Chinese Medical Journal;2024-05-24